Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
17.95
Spread: 0.95 (5.588%)
Market Cap: £22.12m
CRTA Live PriceLast checked at - London Stock Exchange

Intraday Cirata Share Chart

Board Appointment

10 Jun 2025 07:00

RNS Number : 0882M
Cirata PLC
10 June 2025
Β 

10 June 2025

Β 

Cirata plc

("Cirata" or the "Company")

Board Appointment

Β 

Β 

Cirata (LSE: CRTA), is pleased to announce that Sarah Rolls has been appointed as a Non‐Executive Director with immediate effect.

Β 

Sarah has previously served as Group Financial Controller of Sage Group (FTSE 100) and Tate & Lyle (FTSE 250). She is also a trusted Board advisor and business partner, who benefits from 5 years of Big-4 partnership experience. Sarah is experienced across a diverse range of sectors including consumer goods, retail, services and technology, with expertise in financing and tax strategy, risk, financial reporting and controls, M&A and delivering transformational change.

Β 

Sarah has also been appointed as Chair of the Audit and Risk Committee of Cirata with immediate effect.

Β 

Ken Lever, Chair of Cirata, commented:

"Sarah brings a wealth of commercial experience across a range of sectors to our Board. As the former Group Controller of a FTSE 100 company, in addition to a FTSE 250 business, and as a partner at KPMG she has a depth of leadership experience across finance, risk management and governance, which will be of significant benefit to the Cirata Board and the ongoing development of the Company. We are delighted that Sarah has decided to join us."

Β 

Regulatory disclosureΒ -Β The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies:

Β 

Sarah Jane Rolls, agedΒ 50, holds no ordinary shares or options in the Company. Sarah's current and previous directorships are as follows:Β 

Current Directorships/Partnerships

Previous Directorships/Partnerships (last 5 years)

Dry Hill Park Limited

Tonbridge Grammar School

Tate & Lyle Export Holdings Limited

Tate & Lyle Group Services Limited

Tate & Lyle Holdings Americas Limited

Tate & Lyle Holdings Limited

Tate & Lyle Industries Limited

Tate & Lyle International Finance PLC

Tate & Lyle Investments America Limited

Tate & Lyle Investments Brazil Limited

Tate & Lyle Investments Limited

Tate & Lyle Technology Limited

Tate & Lyle UK Limited

ACCPAC UK Limited

HR Bakery Ltd

Interact UK Holdings Limited

KCS Global Holdings Limited

Multisoft Financial Systems Limited

Protx Group Limited

Protx Limited

Sage (UK) Ltd

Sage CRM Solutions Limited

Sage Euro Hedgeco 1

Sage Euro Hedgeco 2

Sage Far East Investments Limited

Sage Global Services Limited

Sage Hibernia Investments No. 1 Limited

Sage Hibernia Investments No. 2 Limited

Sage Holding Company Limited

Sage Holdings Limited

Sage Intacct UK Limited

Sage Irish Investments LLP

Sage Irish Investments One Limited

Sage Irish Investments Two Limited

Sage Management Limited

Sage Online Holdings Limited

Sage Overseas Limited

Sage People Limited

Sage Software Ltd

Sage Treasury Company Limited

Sage USD Hedgeco 1

Sage USD Hedgeco 2

Sage Whitley Limited

Sagesoft

Snowdrop Systems Limited

TAS Software Limited

Sage Irish Finance Company Unlimited Company

Sage Treasury Ireland Unlimited Company

Tate & Lyle Ventures Limited

Β 

Β 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

Β 

Β 

For further information, please contact:Β 

Β 

Cirata

+1 (925) 380 1728

Stephen Kelly, Chief Executive Officer

Ricardo Moura, Chief Financial Officer (Interim)

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Brough Ransom / Ben Good

Panmure Liberum (Joint Broker)

+44 (0)20 3100 2000

Max Jones / John More

Β 

Β 

About Cirata

Β 

Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information aboutΒ Cirata, visitΒ www.cirata.com.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOADZGGVNLGGKZM
Date   Source Headline
1st Jun 20267:00 amRNSBlock Listing Return
20th May 20267:00 amRNSResult of AGM
5th May 20267:00 amRNSHolding(s) in Company
23rd Apr 20268:52 amRNSAmendment to Notice of Annual General Meeting
21st Apr 20267:00 amRNSGrant of Awards & PDMR Dealing
14th Apr 20267:00 amRNSTrading Statement
31st Mar 20263:39 pmRNSManagement Changes
31st Mar 20267:00 amRNSPreliminary Results
4th Feb 20268:54 amRNSGrant of Awards & PDMR Dealing
14th Jan 20267:00 amRNSQ4 FY25 Trading Update
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
1st Dec 20259:35 amRNSBlock Listing Return
27th Nov 20257:00 amRNSFinancial Conduct Authority Update
17th Nov 20257:00 amRNS$6.7m Multiyear Contract win
27th Oct 202510:05 amRNSNotification of Major Holdings
16th Oct 20257:00 amRNSTrading Statement
13th Oct 20257:00 amRNS$3.1m Multiyear Contract with leading US Insurer
12th Sep 202511:02 amRNSGrant of Awards & PDMR Dealing
10th Sep 20257:00 amRNSNotification of Major Holdings
9th Sep 20258:00 amRNS-RCirata launches new data platform
3rd Sep 20257:00 amRNSInterim results
13th Aug 20257:00 amRNSGrant of Share Options to PDMRs
11th Aug 20257:00 amRNSCompletion of DevOps Divestment
15th Jul 20257:07 amRNSQ2 and H1FY25 Trading Update
30th Jun 20257:01 amRNSHolding(s) in Company
30th Jun 20257:00 amRNS$700K Multiyear Data Integration Contract Renewal
10th Jun 20257:00 amRNSBoard Appointment
3rd Jun 20252:39 pmRNSBlock Listing Return
8th May 20254:47 pmRNSResult of AGM
29th Apr 202511:44 amRNSGrant of Share Options to PDMRs
16th Apr 20257:00 amRNSQ1FY25 Trading Statement
8th Apr 20257:00 amRNSAnnual Report & Notice of AGM
2nd Apr 20253:51 pmRNSNotification of Major Holdings
31st Mar 20257:01 amRNSContract win
31st Mar 20257:00 amRNSPreliminary Results
27th Feb 20257:00 amRNSNew logo in Telecom sector
20th Feb 20257:00 amRNSTotal Voting Rights
20th Jan 20256:29 pmRNSPDMR dealings and Total Voting Rights
9th Jan 20257:00 amRNSQ4FY24 Trading Update
16th Dec 20247:00 amRNSContract Win and FY24 Guidance
13th Dec 20243:46 pmRNSVesting of Restricted Stock & Director Dealings
11th Dec 20247:00 amRNSIssue of Equity
9th Dec 20247:00 amRNSMarvell Contract Renewal
2nd Dec 20243:40 pmRNSBlock Listing Return
1st Nov 20247:00 amRNSGrant of Share Options to PDMRs
24th Oct 20247:00 amRNSPDMR Transactions
9th Oct 20247:00 amRNSQ3 Trading Update and Outlook
2nd Oct 20243:19 pmRNSAmendment of OEM sales partnership with IBM
1st Oct 20247:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.